These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. Chintu C; Luo C; Bhat G; Raviglione M; DuPont H; Zumla A Arch Dis Child; 1993 May; 68(5):665-8. PubMed ID: 7686737 [TBL] [Abstract][Full Text] [Related]
3. Use of thiacetazone. Fegan D Lancet; 1995 Jan; 345(8941):63. PubMed ID: 7528312 [No Abstract] [Full Text] [Related]
4. Thiacetazone--use with care. Fegan D Trans R Soc Trop Med Hyg; 1994; 88(6):714. PubMed ID: 7533954 [No Abstract] [Full Text] [Related]
6. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647 [TBL] [Abstract][Full Text] [Related]
7. Severe hypersensitivity reactions among HIV-seropositive patients with tuberculosis treated with thioacetazone. Wkly Epidemiol Rec; 1992 Jan; 67(1-2):1-3. PubMed ID: 1371055 [No Abstract] [Full Text] [Related]
8. Thiacetazone induced skin reactions after an unusual period. Mullick RN; Mullick SB J Indian Med Assoc; 1986 Jun; 84(6):195-6. PubMed ID: 2435812 [No Abstract] [Full Text] [Related]
9. Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies. Kelly P; Buve A; Foster SD; McKenna M; Donnelly M; Sipatunyana G Trans R Soc Trop Med Hyg; 1994; 88(1):113-5. PubMed ID: 7512287 [TBL] [Abstract][Full Text] [Related]
10. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma. Watkins WM; Mungai M; Muhia DK; Mberu EK; Gathua S; Winstanley PA; Gilks CF; Nunn P Br J Clin Pharmacol; 1996 Feb; 41(2):160-2. PubMed ID: 8838444 [TBL] [Abstract][Full Text] [Related]
12. Dermatological hypersensitivity to thiacetazone. Ravindran P; Joshi M Indian J Chest Dis; 1974 Jan; 16(1):58-60. PubMed ID: 4138156 [No Abstract] [Full Text] [Related]
13. Thiacetazone hypersensitivity in two brothers. Varshney DP; Singhal KC; Siddiqi MA Indian J Chest Dis Allied Sci; 1977 Jul; 19(3):131-3. PubMed ID: 77253 [No Abstract] [Full Text] [Related]
15. Thiacetazone skin reaction in Papua New Guinea. Naraqi S; Temu P Med J Aust; 1980 May; 1(10):480-1. PubMed ID: 6157976 [TBL] [Abstract][Full Text] [Related]
16. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana. Lawn SD; Frimpong EH; Acheampong JW West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults. Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099 [TBL] [Abstract][Full Text] [Related]
18. Treatment of tuberculosis in developing countries. Pozniak A Lancet; 1995 Oct; 346(8982):1099. PubMed ID: 7564806 [No Abstract] [Full Text] [Related]
19. Thiacetazone--avoid like poison or use with care? Nunn P; Porter J; Winstanley P Trans R Soc Trop Med Hyg; 1993; 87(5):578-82. PubMed ID: 7505496 [TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity of thiacetazone. Sharda B; Bhandari B Indian Pediatr; 1976 Apr; 13(4):315-6. PubMed ID: 59702 [No Abstract] [Full Text] [Related] [Next] [New Search]